|Bid||7.05 x 100|
|Ask||7.37 x 200|
|Day's Range||7.07 - 7.37|
|52 Week Range||6.15 - 15.40|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||24.67|
Investment company Pharmstandard International S.A. buys Allena Pharmaceuticals Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Pharmstandard International ...
What: Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and ...
--Successfully Completed Initial Public Offering, Raising $74.9 Million in Gross Proceeds-- Presented Final Results from Phase 2 Trials of ALLN-177 in Secondary Hyperoxaluria at ASN Kidney Week 2017-- ...
Allena Pharmaceuticals Inc (NASDAQ:ALNA), a USD$261.28M small-cap, is a healthcare company operating in an industry, which faces demand for new drug development to meet new or persistent chronic illnesses, andRead More...
Investors are always looking for growth in small-cap stocks like Allena Pharmaceuticals Inc (NASDAQ:ALNA), with a market cap of USD $238.80M. However, an important fact which most ignore is: howRead More...